Vivanza Biosciences Limited Share Price
Vivanza Biosciences Limited Share Price Today
As of 5 Jul 2026, Vivanza Biosciences Limited share price is ₹2.00. The stock opened at ₹1.93, compared to its previous close of ₹1.93. During today's trading session, Vivanza Biosciences Limited share price moved in the range of ₹1.93 to ₹2.00, with an average price of ₹1.96 for the day. Looking at its last 52-week, the stock has touched a low of ₹1.52 and a high of ₹2.72.
Vivanza Biosciences Limited Returns Calculator
Vivanza Biosciences Limited Shareholder Returns
Vivanza Biosciences Limited Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Vivanza Biosciences Limited Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹7.42 | ₹27.84 | ₹17.81 | ₹10.40 |
| Other Income | ₹0.06 | ₹0.05 | ₹0.48 | ₹0.83 |
| Total Revenue | ₹7.48 | ₹27.89 | ₹18.28 | ₹11.23 |
| Total Expenses | ₹8.15 | ₹27.19 | ₹17.57 | ₹10.90 |
| Profit Before Tax | -₹0.67 | ₹0.70 | ₹0.72 | ₹0.33 |
| Tax | ₹0.01 | ₹0.15 | ₹0.12 | ₹0.00 |
| Profit After Tax | -₹0.67 | ₹0.55 | ₹0.60 | ₹0.33 |
| EPS - Basic | -₹0.17 | ₹0.14 | ₹1.50 | ₹0.83 |
| EPS - Diluted | -₹0.17 | ₹0.14 | ₹1.50 | ₹0.83 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹0.67 | ₹0.70 | ₹0.72 | ₹0.33 |
| Income before WC changes | -₹0.30 | ₹1.12 | ₹1.14 | ₹0.75 |
| Change in Assets | ₹3.01 | ₹0.52 | -₹4.63 | -₹2.51 |
| Change in Liabilities | -₹5.20 | ₹0.55 | ₹2.66 | ₹4.23 |
| Change in WC | -₹2.19 | ₹1.07 | -₹1.97 | ₹1.72 |
| Cash flow from Operations | -₹2.50 | ₹2.04 | -₹0.95 | ₹2.47 |
| Cash flow from Investing | -₹0.01 | -₹0.04 | ₹0.00 | ₹0.00 |
| Cash flow from Financing | ₹2.46 | -₹1.98 | ₹1.03 | -₹2.48 |
| Total Cash Flow | -₹0.05 | ₹0.03 | ₹0.09 | -₹0.01 |
| Cash (Start of the year) | ₹0.17 | ₹0.14 | ₹0.06 | ₹0.07 |
| Cash (End of the year) | ₹0.12 | ₹0.17 | ₹0.14 | ₹0.06 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹4.07 | ₹3.76 | ₹2.92 | ₹3.11 |
| Current Assets | ₹12.38 | ₹15.74 | ₹19.55 | ₹12.45 |
| Total Assets | ₹16.45 | ₹19.50 | ₹22.48 | ₹15.56 |
| Current Liabilities | ₹9.15 | ₹12.18 | ₹16.95 | ₹9.47 |
| Net Current Asset | ₹3.23 | ₹3.56 | ₹2.60 | ₹2.98 |
| Non-Current Liabilities | ₹3.33 | ₹2.68 | ₹1.43 | ₹2.60 |
| Equity Capital | ₹3.96 | ₹4.64 | ₹4.09 | ₹3.49 |
| Total Equity & Liabilities | ₹16.45 | ₹19.50 | ₹22.48 | ₹15.56 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹2.94 | ₹14.41 | ₹14.21 | ₹9.15 |
| Other Income | ₹0.03 | ₹0.05 | ₹0.39 | ₹0.83 |
| Total Revenue | ₹2.98 | ₹14.47 | ₹14.59 | ₹9.98 |
| Total Expenses | ₹3.67 | ₹14.04 | ₹13.91 | ₹9.51 |
| Profit Before Tax | -₹0.69 | ₹0.43 | ₹0.69 | ₹0.46 |
| Tax | ₹0.00 | ₹0.11 | ₹0.12 | ₹0.00 |
| Profit After Tax | -₹0.70 | ₹0.32 | ₹0.57 | ₹0.46 |
| EPS - Basic | -₹0.17 | ₹0.08 | ₹1.42 | ₹1.16 |
| EPS - Diluted | -₹0.17 | ₹0.08 | ₹1.42 | ₹1.16 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹0.69 | ₹0.43 | ₹0.69 | ₹0.46 |
| Income before WC changes | -₹0.33 | ₹0.85 | ₹1.11 | ₹0.88 |
| Change in Assets | ₹2.95 | ₹1.64 | -₹4.35 | -₹3.12 |
| Change in Liabilities | -₹5.09 | -₹0.59 | ₹3.52 | ₹1.57 |
| Change in WC | -₹2.14 | ₹1.05 | -₹0.83 | -₹1.55 |
| Cash flow from Operations | -₹2.47 | ₹1.80 | ₹0.16 | -₹0.68 |
| Cash flow from Investing | -₹0.01 | -₹0.04 | ₹0.00 | ₹0.00 |
| Cash flow from Financing | ₹2.44 | -₹1.77 | -₹0.08 | ₹0.65 |
| Total Cash Flow | -₹0.04 | -₹0.01 | ₹0.09 | -₹0.03 |
| Cash (Start of the year) | ₹0.09 | ₹0.10 | ₹0.02 | ₹0.05 |
| Cash (End of the year) | ₹0.05 | ₹0.09 | ₹0.10 | ₹0.02 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹2.53 | ₹2.54 | ₹2.51 | ₹2.51 |
| Current Assets | ₹11.38 | ₹14.33 | ₹17.93 | ₹11.70 |
| Total Assets | ₹13.91 | ₹16.87 | ₹20.44 | ₹14.21 |
| Current Liabilities | ₹9.12 | ₹11.38 | ₹16.04 | ₹10.38 |
| Net Current Asset | ₹2.27 | ₹2.95 | ₹1.89 | ₹1.32 |
| Non-Current Liabilities | ₹0.78 | ₹0.78 | ₹0.00 | ₹0.00 |
| Equity Capital | ₹4.02 | ₹4.72 | ₹4.40 | ₹3.83 |
| Total Equity & Liabilities | ₹13.91 | ₹16.87 | ₹20.44 | ₹14.21 |
About Vivanza Biosciences Limited
Vivanza Biosciences Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of pharmaceutical products. Its products include gloves and surgical. Its Gloves products include latex examination gloves powdered, latex surgical powder free, latex free examination gloves-vinyl, latex free examination gloves-nitrile, and latex surgical powdered. The Company’s products catalogues include Injectable Products, Vivanza Gloves, Therapeutic Index Injection, Veterinary Product, and Veterinary Feed. The Company offers gloves and surgical products to the industries include chemical, energy, industry, manufacturing and materials.
Vivanza Biosciences Limited Financial Highlights
- Revenue: Vivanza Biosciences Limited reported revenue of ₹116.02 crore in FY26 vs ₹7.48 crore in FY25. It showed an increase of 1,451.07% on a yearly basis.
- Operating Profit: Vivanza Biosciences Limited reported an operating profit of ₹0.54 crore in FY26 vs ₹0.67 crore in FY25. It showed an increase of 180.60% on a year-on-year basis.
- Net Profit: Vivanza Biosciences Limited reported a net profit of ₹0.39 crore in FY26 vs ₹0.67 crore in FY25. It showed an increase of 158.21% on a yearly basis.
Vivanza Biosciences Limited Quarterly Result Highlights
- Vivanza Biosciences Limited reported revenue of ₹6.37 crore in Mar 2026, compared with ₹45.33 crore in Dec 2025, representing a decrease of 85.95% on a quarter-on-quarter (QoQ) basis.
- Vivanza Biosciences Limited reported an operating loss of ₹0.30 crore in Mar 2026, compared with ₹0.20 crore in Dec 2025, representing a decrease of 250.00% on a quarter-on-quarter (QoQ) basis.
- Vivanza Biosciences Limited reported a loss of ₹0.45 crore in Mar 2026, compared with ₹0.20 crore in Dec 2025, reflecting a decrease of 325.00% on a QoQ basis.
- The earnings per share (EPS) of Vivanza Biosciences Limited stood at ₹0.17 during Mar 2026.
Similar Stocks
FAQs on Vivanza Biosciences Limited Share Price
What is Vivanza Biosciences Limited share price today?
Vivanza Biosciences Limited share price is ₹2.00 as on 03 Jul, 2026, 15:15 IST.
How has the Vivanza Biosciences Limited share price performed in the past?
In the last 1 year, Vivanza Biosciences Limited delivered a return of -6.10%. The Vivanza Biosciences Limited share price hit a high of ₹2.72 and low of ₹1.52.
How much is the Mutual Fund shareholding in Vivanza Biosciences Limited shares?
The Mutual Fund Shareholding in Vivanza Biosciences Limited was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Vivanza Biosciences Limited shares ?
The 52-week high and low of Vivanza Biosciences Limited share is ₹2.72 and ₹1.52 as of 03 Jul, 2026.
What is the market cap of Vivanza Biosciences Limited?
The market capitalisation of Vivanza Biosciences Limited is ₹7.72 Crores as on 03 Jul, 2026.
What are the stock symbols of Vivanza Biosciences Limited?
The stock symbol of Vivanza Biosciences Limited is 530057 on the BSE, and the ISIN is INE984E01035.
What was yesterday's closing price for Vivanza Biosciences Limited shares ?
Vivanza Biosciences Limited shares closed yesterday at ₹1.93 on BSE
How to buy Vivanza Biosciences Limited shares?
To buy Vivanza Biosciences Limited shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Vivanza Biosciences Limited shares on Holidays?
No, shares of Vivanza Biosciences Limited or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Vivanza Biosciences Limited shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Vivanza Biosciences Limited?
The PE and PB ratio of Vivanza Biosciences Limited is 19.3 and 1.77 respectively, as on 03 Jul, 2026, 15:15 IST.